Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wisniewski

Showing results (31-40 of 312) with videos related to

Pageof 32
Sort By:
Frontiers in Aging Neuroscience|November 4, 2021
Editorial: Neurological and Neuroscientific Evidence in Aged COVID-19 PatientsJennifer A Frontera, Thomas Wisniewski
Biochimica Et Biophysica Acta|May 18, 2010
Murine models of Alzheimer's disease and their use in developing immunotherapiesThomas Wisniewski, Einar M Sigurdsson
The FEBS Journal|July 10, 2007
Therapeutic approaches for prion and Alzheimer's diseasesThomas Wisniewski, Einar M Sigurdsson
Handbook of Clinical Neurology|August 24, 2023
Gait dysfunction in Alzheimer diseaseThomas Wisniewski, Arjun V Masurkar
Annals of Neurology|April 13, 2023
Correction: GATA1-Mediated Transcriptional Regulation of the γ-Secretase Activating Protein Increases Aβ Formation in Down SyndromeJin Chu, Thomas Wisniewski, Domenico Pratico
Expert Review of Vaccines|July 15, 2018
Recent advancements toward therapeutic vaccines against Alzheimer's diseaseKrystal Herline, Eleanor Drummond, Thomas Wisniewski
Annals of Neurology|October 9, 2015
GATA1-mediated transcriptional regulation of the γ-secretase activating protein increases Aβ formation in Down syndromeJin Chu, Thomas Wisniewski, Domenico Praticò
Neurobiology of Aging|December 10, 2002
A safer vaccine for Alzheimer's disease?Einar M Sigurdsson, Thomas Wisniewski, Blas Frangione
Trends in Molecular Medicine|September 12, 2002
Infectivity of amyloid diseasesEinar M Sigurdsson, Thomas Wisniewski, Blas Frangione
Journal of Alzheimer'S Disease : JAD|October 9, 2012
Alzheimer's disease: brain desmosterol levelsThomas Wisniewski, Kia Newman, Norman B Javitt
Pageof 32

Showing results (31-40 of 312) with videos related to

Sort By:
Pageof 32
Frontiers in Aging Neuroscience|November 4, 2021
Editorial: Neurological and Neuroscientific Evidence in Aged COVID-19 PatientsJennifer A Frontera, Thomas Wisniewski
Biochimica Et Biophysica Acta|May 18, 2010
Murine models of Alzheimer's disease and their use in developing immunotherapiesThomas Wisniewski, Einar M Sigurdsson
The FEBS Journal|July 10, 2007
Therapeutic approaches for prion and Alzheimer's diseasesThomas Wisniewski, Einar M Sigurdsson
Handbook of Clinical Neurology|August 24, 2023
Gait dysfunction in Alzheimer diseaseThomas Wisniewski, Arjun V Masurkar
Annals of Neurology|April 13, 2023
Correction: GATA1-Mediated Transcriptional Regulation of the γ-Secretase Activating Protein Increases Aβ Formation in Down SyndromeJin Chu, Thomas Wisniewski, Domenico Pratico
Expert Review of Vaccines|July 15, 2018
Recent advancements toward therapeutic vaccines against Alzheimer's diseaseKrystal Herline, Eleanor Drummond, Thomas Wisniewski
Annals of Neurology|October 9, 2015
GATA1-mediated transcriptional regulation of the γ-secretase activating protein increases Aβ formation in Down syndromeJin Chu, Thomas Wisniewski, Domenico Praticò
Neurobiology of Aging|December 10, 2002
A safer vaccine for Alzheimer's disease?Einar M Sigurdsson, Thomas Wisniewski, Blas Frangione
Trends in Molecular Medicine|September 12, 2002
Infectivity of amyloid diseasesEinar M Sigurdsson, Thomas Wisniewski, Blas Frangione
Journal of Alzheimer'S Disease : JAD|October 9, 2012
Alzheimer's disease: brain desmosterol levelsThomas Wisniewski, Kia Newman, Norman B Javitt
Pageof 32